We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
KRT8
HPA
RESOURCES
  • TISSUE
  • BRAIN
  • SINGLE CELL
  • SUBCELLULAR
  • CANCER
  • BLOOD
  • CELL LINE
  • STRUCTURE & INTERACTION
ABOUT
  • INTRODUCTION
  • HISTORY
  • ORGANIZATION
  • PUBLICATIONS
  • ANTIBODY SUBMISSION
  • ANTIBODY AVAILABILITY
  • ACKNOWLEDGMENTS
  • CONTACT
NEWS
  • NEWS ARTICLES
  • PRESS ROOM
LEARN
  • DICTIONARY
  • PROTEIN CLASSES
  • PROTEIN EVIDENCE
  • METHODS
  • EDUCATIONAL VIDEOS
DATA
  • DOWNLOADABLE DATA
  • PUBLICATION DATA
  • RELEASE HISTORY
HELP
  • ANTIBODY VALIDATION
  • ASSAYS & ANNOTATION
  • DISCLAIMER
  • HELP & FAQ
  • PRIVACY STATEMENT
  • LICENCE & CITATION
Fields »
Search result

Field
Term
Gene name
Class
Subclass
Class
Keyword
Chromosome
External id
Tissue
Cell type
Expression
Antibody panel
Tissue
Main location
Patient ID
Annotation
Tissue
Category
Tau score
Cluster
Reliability
Brain region
Category
Tau score
Brain region
Category
Tau score
Brain region
Category
Tau score
Cluster
Reliability
Tissue
Cell type
Enrichment
Cell type
Category
Tau score
Cell type
Category
Tau score
Cell type
Category
Tau score
Cell lineage
Category
Tau score
Cluster
Cluster
Location
Searches
Location
Cell line
Class
Type
Phase
Reliability
Cancer
Prognosis
Cancer
Category
Cancer
Category
Tau score
Cluster
Variants
Interacting gene (ensg_id)
Type
Number of interactions
Pathway
Category
Score
Score
Score
Validation
Validation
Validation
Validation
Antibodies
Data type
Column


  • SUMMARY

  • TISSUE

  • BRAIN

  • SINGLE CELL

  • SUBCELL

  • CANCER

  • BLOOD

  • CELL LINE

  • STRUCT & INT

  • KRT8
CANCER UROTHELIAL CANCER Show tissue menu
BREAST CANCER CARCINOID CERVICAL CANCER COLORECTAL CANCER ENDOMETRIAL CANCER GLIOMA HEAD AND NECK CANCER LIVER CANCER LUNG CANCER LYMPHOMA
MELANOMA OVARIAN CANCER PANCREATIC CANCER PROSTATE CANCER RENAL CANCER SKIN CANCER STOMACH CANCER TESTIS CANCER THYROID CANCER UROTHELIAL CANCER
BLCA TCGA PROTEIN EXPRESSION
ANTIBODIES
AND
VALIDATION
Dictionary
Urothelial cancer
Human cancer
Bladder urothelial carcinoma
BLADDER UROTHELIAL CARCINOMA (TCGA) - Interactive survival scatter ploti

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisi

Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.

KRT8 is not prognostic in Bladder Urothelial Carcinoma (TCGA)


Stage:
Survival analysis
Current cut offi

Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.

:
Best expression cut offi

Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .

When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.

: 2195.21
Median expressioni

Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.

: N/A
Median follow up timei

Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.

: N/A
P scorei

Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.

N/A
5-year survival highi

5-year survival for patients with higher expression than the expression cutoff.

For melanoma and glioma, 3-year survival is shown.

N/A
5-year survival lowi

5-year survival for patients with lower expression than the expression cutoff.

For melanoma and glioma, 3-year survival is shown.

N/A
TCGA RNA samplesi

RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .

Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.

Average pTPM 1521.5
Number of samples 169
Samples
Sample Description pTPM
TCGA-XF-A9T2-01A 54 years, male, white, stage:Stage III, dead, 575 days 9478.6
TCGA-BT-A2LD-01A 78 years, female, white, stage:Stage IV, dead, 623 days 9073.3
TCGA-XF-A9SX-01A 63 years, female, white, stage:Stage IV, dead, 719 days 6684.8
TCGA-XF-AAN2-01A 73 years, male, white, stage:Stage II, dead, 1869 days 6043.3
TCGA-FD-A5BT-01A 84 years, male, white, stage:Stage III, dead, 328 days 5926.1
TCGA-XF-A9SV-01A 82 years, male, white, stage:Stage IV, dead, 388 days 5361.4
TCGA-2F-A9KW-01A 67 years, female, white, stage:Stage III, dead, 254 days 4985.0
TCGA-DK-A1A3-01A 60 years, male, white, stage:Stage IV, dead, 665 days 4526.6
TCGA-FD-A5BZ-01A 77 years, female, white, stage:Stage IV, dead, 835 days 4498.3
TCGA-DK-A3IU-01A 58 years, male, white, stage:Stage II, dead, 706 days 4262.2
TCGA-4Z-AA81-01A 80 years, male, white, stage:Stage II, dead, 1270 days 3798.2
TCGA-FD-A3SM-01A 70 years, male, white, stage:Stage IV, dead, 547 days 3736.7
TCGA-XF-A9SZ-01A 79 years, male, white, stage:Stage IV, dead, 859 days 3277.4
TCGA-S5-A6DX-01A 83 years, male, white, stage:Stage IV, dead, 56 days 3105.8
TCGA-5N-A9KI-01A 76 years, female, white, stage:Stage III, dead, 76 days 3102.9
TCGA-XF-A9SL-01A 69 years, male, white, stage:Stage IV, dead, 2020 days 2950.5
TCGA-GU-A767-01A 81 years, male, white, stage:Stage IV, dead, 144 days 2932.5
TCGA-GU-AATO-01A 75 years, male, white, stage:Stage IV, dead, 324 days 2900.6
TCGA-XF-A8HH-01A 61 years, female, white, stage:Stage IV, dead, 57 days 2851.3
TCGA-FD-A6TI-01A 73 years, male, white, stage:Stage IV, dead, 294 days 2784.6
TCGA-4Z-AA7S-01A 66 years, male, black or african american, stage:Stage III, dead, 1064 days 2770.6
TCGA-FJ-A3ZE-01A 65 years, male, white, stage:Stage IV, dead, 324 days 2761.9
TCGA-FD-A3SL-01A 60 years, male, white, stage:Stage IV, dead, 712 days 2754.4
TCGA-FJ-A3Z9-01A 72 years, male, white, stage:'--, dead, 385 days 2707.0
TCGA-FD-A3SS-01A 66 years, male, white, stage:Stage IV, dead, 391 days 2700.3
TCGA-ZF-AA5N-01A 62 years, female, white, stage:Stage IV, dead, 168 days 2697.2
TCGA-CF-A9FL-01A 85 years, male, asian, stage:Stage III, dead, 565 days 2635.9
TCGA-FD-A6TH-01A 63 years, male, white, stage:Stage IV, dead, 131 days 2603.5
TCGA-XF-A8HI-01A 57 years, female, white, stage:Stage IV, dead, 544 days 2503.4
TCGA-UY-A78K-01A 60 years, male, white, stage:Stage IV, dead, 536 days 2503.4
TCGA-GV-A40E-01A 75 years, male, white, stage:Stage II, dead, 261 days 2488.1
TCGA-UY-A78N-01A 80 years, male, white, stage:Stage IV, dead, 2641 days 2451.4
TCGA-XF-A9ST-01A 68 years, male, white, stage:Stage III, dead, 128 days 2421.7
TCGA-DK-A2HX-01A 80 years, female, white, stage:Stage IV, dead, 1420 days 2378.1
TCGA-BT-A3PH-01A 76 years, male, white, stage:Stage IV, dead, 142 days 2318.5
TCGA-G2-A2EO-01A 69 years, male, white, stage:Stage III, dead, 1804 days 2298.4
TCGA-GU-A42P-01A 72 years, male, white, stage:Stage IV, dead, 332 days 2196.3
TCGA-FD-A3B6-01A 75 years, male, white, stage:Stage II, dead, 1005 days 2195.2
TCGA-CU-A5W6-01A 70 years, male, white, stage:Stage III, dead, 56 days 2181.5
TCGA-DK-A1A5-01A 79 years, male, white, stage:Stage II, dead, 65 days 2099.5
TCGA-DK-A3IN-01A 72 years, male, white, stage:Stage III, dead, 250 days 2088.7
TCGA-XF-AAMH-01A 80 years, male, white, stage:Stage IV, dead, 344 days 2009.8
TCGA-CU-A0YR-01A 83 years, male, white, stage:Stage IV, dead, 460 days 1995.4
TCGA-FD-A3SR-01A 68 years, male, white, stage:Stage IV, dead, 602 days 1990.0
TCGA-DK-AA75-01A 82 years, male, white, stage:Stage III, dead, 340 days 1971.7
TCGA-BT-A20P-01A 81 years, female, white, stage:Stage III, dead, 544 days 1909.6
TCGA-BT-A20W-01A 71 years, male, white, stage:Stage II, dead, 254 days 1897.4
TCGA-XF-AAN1-01A 75 years, female, stage:Stage III, dead, 941 days 1883.0
TCGA-XF-A8HC-01A 79 years, male, asian, stage:Stage IV, dead, 200 days 1859.5
TCGA-FD-A62O-01A 74 years, male, white, stage:Stage IV, dead, 216 days 1858.0
TCGA-FD-A5C0-01A 61 years, male, white, stage:Stage IV, dead, 550 days 1834.8
TCGA-GV-A3QF-01A 79 years, male, white, stage:Stage IV, dead, 617 days 1829.5
TCGA-FD-A6TF-01A 80 years, female, white, stage:Stage IV, dead, 69 days 1814.5
TCGA-ZF-AA4U-01A 70 years, male, white, stage:Stage III, dead, 262 days 1780.5
TCGA-CF-A47T-01A 58 years, female, asian, stage:Stage II, dead, 385 days 1776.5
TCGA-XF-A9SJ-01A 83 years, male, white, stage:Stage IV, dead, 98 days 1707.8
TCGA-BL-A3JM-01A 62 years, male, white, stage:Stage III, dead, 205 days 1698.7
TCGA-XF-A8HF-01A 80 years, male, white, stage:Stage III, dead, 2954 days 1695.5
TCGA-XF-AAML-01A 75 years, male, white, stage:Stage II, dead, 232 days 1638.3
TCGA-2F-A9KP-01A 66 years, male, white, stage:Stage IV, dead, 364 days 1627.2
TCGA-BT-A2LB-01A 73 years, female, white, stage:Stage III, dead, 492 days 1561.9
TCGA-XF-AAMZ-01A 81 years, female, white, stage:Stage IV, dead, 1348 days 1547.1
TCGA-E7-A4XJ-01A 66 years, male, asian, stage:Stage II, dead, 68 days 1545.0
TCGA-DK-A3IL-01A 79 years, female, white, stage:Stage IV, dead, 413 days 1543.6
TCGA-DK-A3IK-01A 87 years, male, white, stage:Stage IV, dead, 146 days 1536.2
TCGA-XF-A9SU-01A 74 years, female, white, stage:Stage IV, dead, 182 days 1492.2
TCGA-ZF-A9R0-01A 82 years, male, white, stage:Stage III, dead, 680 days 1448.1
TCGA-GU-A42R-01A 68 years, male, white, stage:Stage IV, dead, 577 days 1440.1
TCGA-4Z-AA80-01A 73 years, male, white, stage:Stage II, dead, 19 days 1438.5
TCGA-BT-A20V-01A 59 years, female, black or african american, stage:Stage IV, dead, 154 days 1426.4
TCGA-GV-A3QH-01A 67 years, male, white, stage:Stage II, dead, 258 days 1415.7
TCGA-ZF-AA4T-01A 65 years, male, white, stage:Stage IV, dead, 599 days 1398.1
TCGA-E7-A541-01A 66 years, male, white, stage:Stage II, dead, 778 days 1394.1
TCGA-2F-A9KO-01A 63 years, male, white, stage:Stage IV, dead, 734 days 1391.8
TCGA-E7-A3X6-01A 70 years, male, white, stage:Stage II, dead, 904 days 1359.3
TCGA-XF-AAMT-01A 75 years, female, white, stage:Stage IV, dead, 90 days 1346.8
TCGA-ZF-AA52-01A 70 years, male, white, stage:Stage III, dead, 1077 days 1326.2
TCGA-E7-A97P-01A 73 years, male, asian, stage:Stage II, dead, 437 days 1318.2
TCGA-XF-AAMX-01A 87 years, female, black or african american, stage:Stage III, dead, 206 days 1317.1
TCGA-ZF-A9RN-01A 67 years, female, white, stage:Stage III, dead, 615 days 1260.1
TCGA-FD-A62P-01A 76 years, male, white, stage:Stage II, dead, 191 days 1256.3
TCGA-GV-A3JV-01A 66 years, male, white, stage:Stage IV, dead, 434 days 1234.8
TCGA-FD-A5BV-01A 47 years, female, white, stage:Stage III, dead, 163 days 1210.6
TCGA-BT-A20T-01A 63 years, male, white, stage:Stage IV, dead, 453 days 1205.9
TCGA-BT-A20Q-01A 73 years, male, white, stage:Stage IV, dead, 593 days 1198.8
TCGA-GC-A3BM-01A 70 years, male, white, stage:Stage II, dead, 651 days 1187.4
TCGA-FD-A6TD-01A 77 years, male, white, stage:Stage III, dead, 386 days 1161.7
TCGA-G2-A3IE-01A 51 years, male, white, stage:Stage II, dead, 612 days 1077.7
TCGA-C4-A0F7-01A 77 years, male, stage:Stage IV, dead, 62 days 1074.5
TCGA-5N-A9KM-01A 73 years, female, white, stage:Stage III, dead, 530 days 1061.0
TCGA-GU-AATQ-01A 68 years, male, white, stage:Stage III, dead, 213 days 1049.9
TCGA-ZF-A9R3-01A 53 years, female, white, stage:Stage II, dead, 949 days 957.3
TCGA-HQ-A5NE-01A 57 years, male, stage:Stage III, dead, 370 days 953.2
TCGA-4Z-AA7N-01A 65 years, male, white, stage:Stage III, dead, 1367 days 941.0
TCGA-BT-A0S7-01A 75 years, male, white, stage:Stage III, dead, 200 days 939.2
TCGA-DK-A3X2-01A 85 years, male, white, stage:Stage IV, dead, 547 days 933.1
TCGA-XF-A9SK-01A 65 years, male, white, stage:Stage IV, dead, 486 days 892.9
TCGA-2F-A9KR-01A 59 years, female, stage:Stage III, dead, 3183 days 882.8
TCGA-CU-A0YO-01A 84 years, male, white, stage:Stage IV, dead, 149 days 874.9
TCGA-DK-A3IQ-01A 74 years, male, white, stage:Stage III, dead, 539 days 865.1
TCGA-BT-A20U-01A 70 years, female, white, stage:Stage III, dead, 455 days 844.4
TCGA-HQ-A5ND-01A 78 years, male, stage:Stage IV, dead, 274 days 841.1
TCGA-GU-A762-01A 87 years, male, white, stage:Stage IV, dead, 232 days 801.2
TCGA-SY-A9G0-01A 82 years, male, white, stage:Stage IV, dead, 1008 days 801.1
TCGA-UY-A78M-01A 81 years, female, asian, stage:Stage IV, dead, 690 days 797.5
TCGA-XF-AAN0-01A 68 years, male, white, stage:Stage IV, dead, 1718 days 796.3
TCGA-DK-AA6L-01A 48 years, male, white, stage:Stage IV, dead, 1163 days 794.3
TCGA-DK-A2I2-01A 63 years, female, white, stage:Stage IV, dead, 237 days 793.2
TCGA-XF-A9SP-01A 59 years, male, white, stage:Stage III, dead, 454 days 791.9
TCGA-4Z-AA86-01A 66 years, male, black or african american, stage:Stage IV, dead, 311 days 791.4
TCGA-G2-A2EC-01A 58 years, female, black or african american, stage:Stage II, dead, 696 days 780.3
TCGA-FD-A3B7-01A 66 years, male, black or african american, stage:Stage III, dead, 122 days 757.1
TCGA-ZF-AA56-01A 79 years, female, white, stage:Stage III, dead, 259 days 751.0
TCGA-C4-A0EZ-01A 69 years, female, stage:Stage IV, dead, 273 days 740.4
TCGA-FD-A6TG-01A 73 years, male, white, stage:Stage IV, dead, 93 days 713.2
TCGA-DK-AA6W-01A 78 years, male, white, stage:Stage II, dead, 415 days 710.5
TCGA-YC-A9TC-01A 71 years, male, white, stage:Stage IV, dead, 20 days 699.3
TCGA-XF-AAMW-01A 79 years, female, white, stage:Stage IV, dead, 253 days 698.5
TCGA-DK-AA6Q-01A 61 years, female, white, stage:Stage IV, dead, 413 days 668.9
TCGA-FD-A3SJ-01A 59 years, male, white, stage:Stage IV, dead, 739 days 658.8
TCGA-ZF-AA4R-01A 67 years, male, white, stage:Stage IV, dead, 1036 days 645.3
TCGA-BT-A20J-01A 75 years, male, white, stage:Stage II, dead, 579 days 628.1
TCGA-BL-A13J-01A 65 years, male, white, stage:Stage IV, dead, 81 days 612.4
TCGA-ZF-A9RE-01A 78 years, female, white, stage:Stage II, dead, 106 days 584.8
TCGA-BT-A3PK-01A 80 years, male, white, stage:Stage II, dead, 303 days 571.8
TCGA-4Z-AA7R-01A 73 years, male, black or african american, stage:Stage IV, dead, 522 days 570.5
TCGA-XF-A9SW-01A 85 years, male, white, stage:Stage IV, dead, 362 days 558.8
TCGA-ZF-A9R9-01A 58 years, male, white, stage:Stage IV, dead, 864 days 550.3
TCGA-4Z-AA82-01A 59 years, male, black or african american, stage:Stage IV, dead, 1556 days 543.3
TCGA-K4-A5RI-01A 67 years, female, white, stage:Stage III, dead, 356 days 510.3
TCGA-G2-A3IB-01A 66 years, male, black or african american, stage:Stage II, dead, 220 days 482.5
TCGA-FD-A3SQ-01A 62 years, male, white, stage:Stage IV, dead, 1423 days 471.8
TCGA-FD-A3B5-01A 86 years, male, black or african american, stage:Stage IV, dead, 272 days 467.4
TCGA-DK-A1AB-01A 74 years, female, white, stage:Stage IV, dead, 508 days 433.7
TCGA-FD-A3N5-01A 69 years, male, black or african american, stage:Stage II, dead, 685 days 430.1
TCGA-BT-A20N-01A 72 years, male, stage:Stage III, dead, 795 days 426.8
TCGA-XF-AAN7-01A 60 years, male, white, stage:Stage IV, dead, 565 days 373.8
TCGA-G2-AA3C-01A 66 years, male, white, stage:Stage IV, dead, 211 days 360.9
TCGA-XF-A8HG-01A 69 years, male, white, stage:Stage III, dead, 467 days 324.1
TCGA-FD-A3B3-01A 74 years, female, white, stage:Stage III, dead, 974 days 313.3
TCGA-G2-A2EL-01A 77 years, male, white, stage:Stage II, dead, 819 days 295.9
TCGA-XF-A9SH-01A 65 years, female, asian, stage:Stage II, dead, 1971 days 275.2
TCGA-CU-A72E-01A 76 years, male, white, stage:Stage IV, dead, 413 days 247.9
TCGA-XF-AAMJ-01A 70 years, male, asian, stage:Stage III, dead, 1670 days 247.8
TCGA-ZF-A9RD-01A 75 years, female, white, stage:Stage IV, dead, 408 days 244.2
TCGA-FD-A43Y-01A 65 years, male, white, stage:Stage III, dead, 474 days 238.5
TCGA-GU-A42Q-01A 67 years, male, white, stage:Stage III, dead, 344 days 232.7
TCGA-K4-A4AC-01A 83 years, male, white, stage:Stage II, dead, 278 days 223.6
TCGA-GC-A3I6-01A 45 years, male, white, stage:Stage III, dead, 630 days 221.2
TCGA-XF-AAN4-01A 77 years, female, white, stage:Stage III, dead, 823 days 183.4
TCGA-FD-A62S-01A 60 years, female, black or african american, stage:Stage III, dead, 406 days 177.1
TCGA-DK-A3IM-01A 76 years, male, white, stage:Stage III, dead, 248 days 157.6
TCGA-XF-AAME-01A 64 years, female, white, stage:Stage II, dead, 2828 days 144.1
TCGA-E5-A4TZ-01A 64 years, male, white, stage:Stage IV, dead, 467 days 130.5
TCGA-BT-A0YX-01A 70 years, female, white, stage:Stage III, dead, 400 days 126.7
TCGA-XF-A9T8-01A 64 years, male, white, stage:Stage III, dead, 418 days 94.2
TCGA-FJ-A871-01A 49 years, male, white, stage:Stage III, dead, 272 days 84.9
TCGA-G2-A2ES-01A 85 years, male, white, stage:Stage II, dead, 1004 days 78.6
TCGA-CU-A0YN-01A 60 years, male, white, stage:Stage III, dead, 393 days 75.7
TCGA-FD-A5BX-01A 82 years, male, white, stage:Stage IV, dead, 173 days 74.3
TCGA-FD-A3B4-01A 55 years, female, black or african american, stage:Stage III, dead, 510 days 58.5
TCGA-4Z-AA7Q-01A 79 years, male, white, stage:Stage III, dead, 510 days 51.2
TCGA-BT-A20X-01A 56 years, male, white, stage:Stage IV, dead, 251 days 34.2
TCGA-XF-AAN8-01A 74 years, female, white, stage:Stage III, dead, 118 days 25.8
TCGA-BL-A13I-01A 57 years, female, white, stage:Stage III, dead, 223 days 17.4
TCGA-ZF-AA54-01A 71 years, male, white, stage:Stage III, dead, 590 days 14.2
TCGA-ZF-AA4N-01A 74 years, male, white, stage:Stage II, dead, 88 days 11.1
TCGA-FD-A3SO-01A 68 years, male, white, stage:Stage IV, dead, 168 days 4.0
TCGA-BT-A20O-01A 75 years, male, white, stage:Stage III, dead, 370 days 0.0
Show allShow less
UROTHELIAL CANCER - Protein expressioni

A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here.

Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.

 

Antibody stainingi

Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells.

Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.


Antibody HPA049866

Antibody CAB000131

Antibody CAB001696
 Staining
  High
  Medium
  Low
  Not detected
 Intensity
  Strong
  Moderate
  Weak
  Negative
 Quantity
  >75%
  75%-25%
  <25%
  None
 Location
  Nuclear
  Cytoplasmic/membranous
  Cytoplasmic/membranous,nuclear
  None
Urothelial carcinoma, High grade
Urothelial carcinoma, Low grade
Adenocarcinoma, NOS

Contact

  • NEWS ARTICLES
  • PRESS ROOM

The Project

  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS

The Human Protein Atlas

  • DOWNLOADABLE DATA
  • LICENCE & CITATION
  • HELP & FAQ
The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg Foundation.


contact@proteinatlas.org